Common Stock, Shares, Issued of Inhibrx, Inc. from 31 Dec 2019 to 31 Mar 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Inhibrx, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2019 to 31 Mar 2024.
  • Inhibrx, Inc. Common Stock, Shares, Issued for the quarter ending 31 Mar 2024 was 49,234,225, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Inhibrx, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 49,234,225 +5,639,333 +13% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 47,369,511 +3,805,228 +8.7% 31 Dec 2023 10-Q 09 May 2024 2024 Q1
Q3 2023 47,290,666 +8,203,493 +21% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 43,667,374 +4,625,540 +12% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 43,594,892 +4,568,423 +12% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 43,564,283 +4,572,976 +12% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 39,087,173 +1,154,127 +3% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 39,041,834 +1,192,809 +3.2% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 39,026,469 +1,221,372 +3.2% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 38,991,307 +1,278,917 +3.4% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 37,933,046 +222,856 +0.59% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 37,849,025 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 37,805,097 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 37,712,390 +19,558,271 +108% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 37,710,190 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q4 2019 18,154,119 31 Dec 2019 10-K 12 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.